ICIJ ✓
@ICIJorg · International · joined 11 Apr 2010
Stories that rock the world. We expose wrongdoing so the world can make it right. #CyprusConfidential #UberFiles #PandoraPapers #FinCENFiles #PanamaPapers
486 218Followers
1 123Following
31 625Posts total
154.4KViews on collected posts
Latest posts
Looking for new posts…
Join us for "Inside #ChinaCapital"!
On Sept. 29 at 12 p.m. ET, ICIJ reporter Scilla Alecci and Bradley C. Parks, executive director of AidData at William & Mary, will discuss the global implications of ICBC’s lending practices in a live Zoom panel.
Sign up:
1.8K views · 0 likes
· 0 reposts · 0 replies
Open on X →
Catch up with ICIJ at the Breakwater Festival!
On Saturday, Sept. 26, @delreuter will join a panel to reflect on what changed – or didn't – 10 years after the #PanamaPapers investigation.
See you at the "Why Are the Rich Still Getting Away With It?" panel!
3.6K views · 0 likes
· 1 reposts · 0 replies
Open on X →
From New Zealand to Mexico, the #ChinaCapital investigation team uncovered strategic deals and moves the Industrial and Commercial Bank of China made around the world to further the political priorities of the party-state.
Here are some of the revelations:
7.2K views · 31 likes
· 16 reposts · 0 replies
Open on X →
From @Bellingcat: Christy Kinahan, the founder of the Kinahan Organized Crime Group, has had his United Arab Emirates residence permit cancelled just weeks after the extradition of his eldest son Daniel Kinahan from Dubai to Ireland. https://t.co/7UNXP00FCr
7.7K views · 39 likes
· 14 reposts · 0 replies
Open on X →
#ChinaCapital: ICIJ’s newest global investigation with 23 media partners exposes how the world’s biggest bank, the Industrial and Commercial Bank of China, maneuvers behind closed doors to help Beijing achieve its geopolitical goals. https://t.co/v7tzFBSZMW https://t.co/3ravgG8lL
50.9K views · 221 likes
· 126 reposts · 9 replies
Open on X →
1:45
ICIJ's reporting found that in Tether’s early days, the firm underwent large changes to its ownership that experts say appeared unusual. We found indications that one executive, Giancarlo Devasini, may have recently increased his control over the firm. https://t.co/OBDFVNkOid
6.4K views · 5 likes
· 2 reposts · 0 replies
Open on X →
A new ICIJ analysis shows the Met still holds hundreds of objects once owned by dealers who were indicted or convicted of antiquities crimes — the very same people who account for most of the antiquities seized from the museum in recent years. https://t.co/YYHrh1EzA0
4.7K views · 12 likes
· 2 reposts · 0 replies
Open on X →
Join ICIJ at the Breakwater Festival in Poland!
On Friday, Sept. 25, @jecosic and @delreuter will show how they used blockchain exploration tools for ICIJ's #CoinLaundry investigation in the "How to Start Investigating Crypto" session.
Don't miss it! https://t.co/OyzyahSpbN
4.4K views · 5 likes
· 1 reposts · 0 replies
Open on X →
A massive oil deal between the U.S. and Venezuela has revived the profile of Alejandro Betancourt, a businessman under investigation in Spain and Switzerland on suspicion of laundering billions out of Venezuela and into the European financial system. https://t.co/xa0ZI5BYCv
8.6K views · 18 likes
· 11 reposts · 0 replies
Open on X →
Yorgen Fenech, the businessman accused of orchestrating the killing of Maltese journalist Daphne Caruana Galizia, was found not guilty on all charges.
A Maltese jury returned an 8-1 verdict in his favor. The prosecution is expected to appeal the verdict. https://t.co/VRVfVhkT6J
6.4K views · 25 likes
· 5 reposts · 0 replies
Open on X →
An ICIJ review found cancer drug makers have paid over $1.7 billion in settlements and fines over a 15-year period. But those payments often make up less than 1% of their revenues – and experts said many companies see them as the cost of doing business. https://t.co/l1jBe35EKi
3.3K views · 10 likes
· 8 reposts · 1 replies
Open on X →
From @FT: Swiss wealth managers are urging the government to halt the launch of a vast new register of company owners after hackers stole similar data on thousands of people from neighboring country Liechtenstein. https://t.co/Kc0cWu1uk0
4.7K views · 5 likes
· 3 reposts · 0 replies
Open on X →
Congratulations to the team behind ICIJ's #DamascusDossier investigation for becoming a finalist on @ONA's Online Journalism Awards in the Single Story category for Excellence in Social Justice Reporting!
Read the announcement here: https://t.co/kUW69ILFGm
6K views · 6 likes
· 3 reposts · 1 replies
Open on X →
From @DowJones Risk Journal: A father and son who co-own an Argentine sports marketing company featured in the #PanamaPapers are set to admit to bribing international soccer officials in exchange for marketing rights to valuable matches, prosecutors said. https://t.co/6YPvXSuqzZ
6.7K views · 6 likes
· 4 reposts · 0 replies
Open on X →
@ICIJorg The costs of keytruda is around $10,000 per 200mg course. Similar PD1 and PDL1 drugs in China costs $600. China is going to win long term if it exports these drugs.
187 views · 5 likes
· 0 reposts · 1 replies
Open on X →
Some patients have turned to the courts for access to Keytruda, only to die waiting. Others have paid thousands of dollars out of pocket before their insurers complied with courts’ or regulators’ orders. https://t.co/ZbCXhupafA
1K views · 4 likes
· 2 reposts · 1 replies
Open on X →
The #CancerCalculus investigation pulls the curtain back on precisely how Merck maintains Keytruda’s dominance.
Want to learn more? Read our FAQs: https://t.co/d5ZNjX5JUN
1.1K views · 8 likes
· 3 reposts · 0 replies
Open on X →
ICIJ’s investigation found that Merck’s list prices, or the initial undiscounted prices, vary wildly across countries, ranging from about $850 for a single 100 mg vial in Indonesia to $6,015 for the same vial in the U.S. https://t.co/VQnqrnN6QW https://t.co/i1jlRVG8C4
336 views · 7 likes
· 2 reposts · 1 replies
Open on X →
This dynamic has created a dangerous opening: new opportunities for counterfeiters to cash in on demand for costly oncology medicines as cancer rates soar.
In Mexico, ICIJ and partners identified four cases in which fake Keytruda was supplied to hospitals.
366 views · 4 likes
· 1 reposts · 1 replies
Open on X →
Keytruda’s primary patents are set to expire in 2028, but ICIJ found that Merck has continued to file and obtain secondary patents beyond the drug's main pharmaceutical component, potentially extending its commercial exclusivity until at least 2042 in the U.S.
643 views · 7 likes
· 5 reposts · 1 replies
Open on X →
Known generically as pembrolizumab, Keytruda is a game changer in cancer treatment, weaponizing a patient’s immune system against cancer cells. In the U.S., the FDA has approved it for 19 tumor types. https://t.co/zbaq9mo58I
655 views · 8 likes
· 2 reposts · 1 replies
Open on X →
#CancerCalculus: An ICIJ-led collaboration with 47 media partners in 37 countries reveals how Merck & Co. keeps the price of its lifesaving cancer drug Keytruda sky-high, locking out patients and squeezing health care systems worldwide. https://t.co/Zo4ZGf1NJ8 https://t.co/0jc9Fa
26.7K views · 171 likes
· 143 reposts · 21 replies
Open on X →
The yearlong investigation by 100+ journalists also sheds new light on the strategies that have allowed Merck to widen Keytruda’s use — even in cases where the benefits are limited and lower dosages may be just as effective. https://t.co/VQnqrnN6QW
1K views · 9 likes
· 6 reposts · 1 replies
Open on X →
Against accounts of the same size
14 posts from the last 90 days, next to the 100K–1M follower range. ordinary reach for its size, weaker reaction than most.
Median views6 168this account5 983median for 100K–1M
Reach, %1.27%this account1.49%median for 100K–1M
Engagement, %0.23%this account0.93%median for 100K–1M
| Metric | This account | Median for 100K–1M | Ratio |
|---|---|---|---|
| Median views per post | 6 168 | 5 983 | 1.03× |
| Reach (views ÷ followers) | 1.27% | 1.49% | 0.85× |
| Engagement rate | 0.23% | 0.93% | 0.25× |
Others in this range → Compare with another account → How these benchmarks are built →
Growth & engagement
How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.
Views per post
6.7K1 Sep
6K
4.7K2 Sep
3.3K
6.4K3 Sep
8.6K
4.4K4 Sep
4.7K
6.4K5 Sep
50.9K14 Sep
7.7K23 Sep
7.2K
3.6K24 Sep
1.8K
Last 14 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.
Engagement rate per post
0.15%1 Sep
0.17%
0.17%2 Sep
0.58%
0.48%3 Sep
0.37%
0.14%4 Sep
0.29%
0.14%5 Sep
0.73%14 Sep
0.70%23 Sep
0.66%
0.03%24 Sep
0.00%
Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.
What the audience does
Likes50.1%606 in total
Reposts29.8%360 in total
Replies3.2%39 in total
Quotes2.5%30 in total
Bookmarks14.4%174 in total
Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.
The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.
Similar accounts
DANIEL HABIF ✓
@DanielHabif
972.4K followers
· 42.7K posts
Daniel Dale ✓
@ddale8
972.1K followers
· 111K posts
癒月ちょこ💋@ホロライブ ✓
@yuzukichococh
971.9K followers
· 33K posts
Evreni Merak Ediyoruz ✓
@evrenseImerak
971.9K followers
· 12.5K posts
Perú21 ✓
@peru21noticias
971.9K followers
· 542.4K posts
NBC Nightly News with Tom Llamas ✓
@NBCNightlyNews
971.9K followers
· 203.6K posts
Joan Laporta Estruch ✓
@JoanLaportaFCB
971.4K followers
· 3.5K posts
#19 ✓
@Sch_Mathafack
971.4K followers
· 16.5K posts